These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Combined evaluation of a panel of protein and miRNA serum-exosome biomarkers for pancreatic cancer diagnosis increases sensitivity and specificity. Madhavan B, Yue S, Galli U, Rana S, Gross W, Müller M, Giese NA, Kalthoff H, Becker T, Büchler MW, Zöller M. Int J Cancer; 2015 Jun 01; 136(11):2616-27. PubMed ID: 25388097 [Abstract] [Full Text] [Related]
23. MicroRNA-100 shuttled by mesenchymal stem cell-derived exosomes suppresses in vitro angiogenesis through modulating the mTOR/HIF-1α/VEGF signaling axis in breast cancer cells. Pakravan K, Babashah S, Sadeghizadeh M, Mowla SJ, Mossahebi-Mohammadi M, Ataei F, Dana N, Javan M. Cell Oncol (Dordr); 2017 Oct 01; 40(5):457-470. PubMed ID: 28741069 [Abstract] [Full Text] [Related]
24. Analysis of miRNA-221 Expression Level in Tumors and Marginal Biopsies from Patients with Breast Cancer (Cross-Sectional Observational Study). Abak A, Amini S, Estiar MA, Montazeri V, Sakhinia E, Abhari A. Clin Lab; 2018 Jan 01; 64(1):169-175. PubMed ID: 29479893 [Abstract] [Full Text] [Related]
29. The prognostic and therapeutic application of microRNAs in breast cancer: Tissue and circulating microRNAs. Bahrami A, Aledavood A, Anvari K, Hassanian SM, Maftouh M, Yaghobzade A, Salarzaee O, ShahidSales S, Avan A. J Cell Physiol; 2018 Feb 01; 233(2):774-786. PubMed ID: 28109133 [Abstract] [Full Text] [Related]
31. Evaluation of exosomal miR-9 and miR-155 targeting PTEN and DUSP14 in highly metastatic breast cancer and their effect on low metastatic cells. Kia V, Paryan M, Mortazavi Y, Biglari A, Mohammadi-Yeganeh S. J Cell Biochem; 2019 Apr 01; 120(4):5666-5676. PubMed ID: 30335891 [Abstract] [Full Text] [Related]
33. Combined detection of plasma miR-127-3p and HE4 improves the diagnostic efficacy of breast cancer. Lu M, Ju S, Shen X, Wang X, Jing R, Yang C, Chu H, Cong H. Cancer Biomark; 2017 Apr 01; 18(2):143-148. PubMed ID: 27983524 [Abstract] [Full Text] [Related]
36. Study on the relationship between miR-520g and the development of breast cancer. Ren GB, Wang L, Zhang FH, Meng XR, Mao ZP. Eur Rev Med Pharmacol Sci; 2016 Apr 01; 20(4):657-63. PubMed ID: 26957267 [Abstract] [Full Text] [Related]
38. Effect of exosome biomarkers for diagnosis and prognosis of breast cancer patients. Wang M, Ji S, Shao G, Zhang J, Zhao K, Wang Z, Wu A. Clin Transl Oncol; 2018 Jul 01; 20(7):906-911. PubMed ID: 29143228 [Abstract] [Full Text] [Related]
39. Exosomes from adriamycin-resistant breast cancer cells transmit drug resistance partly by delivering miR-222. Yu DD, Wu Y, Zhang XH, Lv MM, Chen WX, Chen X, Yang SJ, Shen H, Zhong SL, Tang JH, Zhao JH. Tumour Biol; 2016 Mar 01; 37(3):3227-35. PubMed ID: 26432333 [Abstract] [Full Text] [Related]
40. Matrix metalloproteinase localisation by in situ-RT-PCR in archival human breast biopsy material. Haupt LM, Irving RE, Weinstein SR, Irving MG, Griffiths LR. Mol Cell Probes; 2008 Apr 01; 22(2):83-9. PubMed ID: 17669621 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]